REFERENCES
- Whitley RJ. Epidemiology of herpes simplex viruses. In: The herpesviruses. Vol. 3, Ed. Roizman B., Plenum Press, New York 1985: 1-44.
- Chatterjee S, Hunter E, Whitley R. Effect of cloned human interferons on protein synthesis and morphogenesis of herpes simplex virus. J Virol 1985; 56, 419–25.
- Muratore O, Tonoli EL, Pesce Schito A, Schito GC, Sacca SC, Ghiglione D, Ciurlo G. The mixed leukocyte reac-tion may promote the growth of human pericomeal fibrob-lasts in primary culture. Microbiologica 1994; 17, 141–46.
- Whitley RJ. Approaches to therapy of viral infections. Adv Pediatr 1987; 34: 89–110.
- Wood MJ, Geddes AM. Antiviral therapy. Lancet 1987; ii: 1189–93.
- Muratore O, Pesce Schito A, Mosti L, Sansebastiano L, Schito GC. S-7 inhibition of herpes simplex virus type 1 infectivity and replication in cultured cells. J Chemother 1991; Suppl. 1, 3: 84-85.
- Muratore O, Vamier OE, Raffanti SP, Schito GC. In vitro recovery of resistant retrovirus isolates after exposure to phosphonoformate. Eur J Clin Microbiol 1984; 3: 447-449. Muratore O. Murine retroviruses: an alternative screen-ing approach for antiviral drug research. In: Gallo R.C., Stehelin D., Vamier O.E., eds., Proc. Int. Symp.: Retroviruses and human pathology. Humana Press, Clifton, 1985; 85: 145–50.
- Muratore O, Pesce Schito A, Petta A, Schito GC. Studies to define a plaque assay which utilizes a single cycle of infection in Vero cell cultures for herpes simplex virus type 1. Eur Bull Drug Res 1993; 2, Suppl. 1: 151-3.
- Sansebastiano L, Mosti L, Schenone P et al.: Synthesis, antiviral (HSV-1) and antimycotic activities of ethyl or methyl 2,4-disubstituted 5-pyrimidinecarboxylates, 2,4-disubstituted 5-pyrimidinecarboxylic acids and 2,4-disubstituted pyrim-idines. II Farmaco, 1993; 48: 335-55.
- Baichwal VR, Sugden B. Latency comes of age for her-pesviruses. Cell 1988; 52, 787–9.
- Roizman B, Sears AE. An inquiry into the mechanisms of herpes simplex virus latency. Ann Rev Microbiol 1987; 41, 543–71.
- Dolin R. Antiviral chemotherapy and chemoprophylax-is. Science 1985; 227: 1296–303.
- Albrecht MA, DeLuca NA, Byrn RA, Schaffer PA, Hammer SM. The herpes simplex virus immediate-early pro-tein ICP4, is required to potentiate replication of human immunodeficiency virus in CD4+ lymphocytes. J Virol 1989; 63: 1861–8.